rs910315

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_152443.3(RDH12):​c.-219-218A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.089 in 152,108 control chromosomes in the GnomAD database, including 853 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.089 ( 853 hom., cov: 32)

Consequence

RDH12
NM_152443.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.239

Publications

2 publications found
Variant links:
Genes affected
RDH12 (HGNC:19977): (retinol dehydrogenase 12) The protein encoded by this gene is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. The encoded enzyme also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 13 and Retinitis Pigmentosa 53. [provided by RefSeq, Sep 2015]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 14-67722206-A-G is Benign according to our data. Variant chr14-67722206-A-G is described in ClinVar as Benign. ClinVar VariationId is 1231282.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152443.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RDH12
NM_152443.3
MANE Select
c.-219-218A>G
intron
N/ANP_689656.2A0A0S2Z613

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RDH12
ENST00000551171.6
TSL:1 MANE Select
c.-219-218A>G
intron
N/AENSP00000449079.1Q96NR8
RDH12
ENST00000267502.3
TSL:5
c.-219-218A>G
intron
N/AENSP00000267502.3Q96NR8

Frequencies

GnomAD3 genomes
AF:
0.0888
AC:
13494
AN:
151990
Hom.:
851
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.0769
Gnomad AMR
AF:
0.143
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.0956
Gnomad FIN
AF:
0.0240
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0426
Gnomad OTH
AF:
0.0845
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0890
AC:
13537
AN:
152108
Hom.:
853
Cov.:
32
AF XY:
0.0890
AC XY:
6618
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.148
AC:
6155
AN:
41472
American (AMR)
AF:
0.144
AC:
2190
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
111
AN:
3468
East Asian (EAS)
AF:
0.232
AC:
1198
AN:
5160
South Asian (SAS)
AF:
0.0967
AC:
466
AN:
4820
European-Finnish (FIN)
AF:
0.0240
AC:
254
AN:
10602
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0425
AC:
2893
AN:
68006
Other (OTH)
AF:
0.0860
AC:
182
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
604
1208
1813
2417
3021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0591
Hom.:
234
Bravo
AF:
0.104
Asia WGS
AF:
0.163
AC:
564
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.91
DANN
Benign
0.62
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs910315; hg19: chr14-68188923; API